Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Biochem Pharmacol. 2013 Aug 5;86(6):824–835. doi: 10.1016/j.bcp.2013.07.023

Figure 9. Compound 1 activate PXR-regulated CYP2B6 promoter activity in HepG2 cells.

Figure 9

HepG2 cells transiently transfected with hPXR, CYP2B6-luc, and CMV-Renilla were treated for 24 h with indicated concentrations of rifampicin or compound 1 prior to luciferase assay.